• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白和tau 与线粒体功能障碍的关联更新:对帕金森病的影响。

Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.

机构信息

Department of Anatomy, School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Eur J Neurosci. 2021 May;53(9):2946-2959. doi: 10.1111/ejn.14699. Epub 2020 Feb 25.

DOI:10.1111/ejn.14699
PMID:32031280
Abstract

The critical role of mitochondrial dysfunction in the pathological mechanisms of neurodegenerative disorders, particularly Parkinson's disease (PD), is well established. Compelling evidence indicates that Parkinson's proteins (e.g., α-synuclein, Parkin, PINK1, DJ-1, and LRRK2) are associated with mitochondrial dysfunction and oxidative stress in PD. Significantly, there is a possible central role of alpha-synuclein (α-Syn) in the occurrence of mitochondrial dysfunction and oxidative stress by the mediation of different signaling pathways. Also, tau, traditionally considered as the main component of neurofibrillary tangles, aggregates and amplifies the neurotoxic effects on mitochondria by interacting with α-Syn. Moreover, oxidative stress caused by mitochondrial dysfunction favors assembly of both α-Syn and tau and also plays a key role in the formation of protein aggregates. In this review, we provide an overview of the relationship between these two pathological proteins and mitochondrial dysfunction in PD, and also summarize the underlying mechanisms in the interplay of α-Syn aggregation and phosphorylated tau targeting the mitochondria, to find new strategies to prevent PD processing.

摘要

线粒体功能障碍在神经退行性疾病(尤其是帕金森病,PD)的病理机制中起着至关重要的作用,这一点已得到充分证实。有确凿的证据表明,帕金森蛋白(例如α-突触核蛋白、Parkin、PINK1、DJ-1 和 LRRK2)与 PD 中的线粒体功能障碍和氧化应激有关。值得注意的是,α-突触核蛋白(α-Syn)通过不同的信号通路介导,可能在线粒体功能障碍和氧化应激的发生中发挥核心作用。此外,tau 传统上被认为是神经原纤维缠结的主要成分,通过与 α-Syn 相互作用聚集并放大对线粒体的神经毒性作用。此外,线粒体功能障碍引起的氧化应激有利于 α-Syn 和 tau 的组装,并且在蛋白质聚集体的形成中也起着关键作用。在这篇综述中,我们概述了这两种病理蛋白与 PD 中线粒体功能障碍之间的关系,并总结了 α-Syn 聚集和磷酸化 tau 靶向线粒体相互作用的潜在机制,以寻找预防 PD 进展的新策略。

相似文献

1
Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.α-突触核蛋白和tau 与线粒体功能障碍的关联更新:对帕金森病的影响。
Eur J Neurosci. 2021 May;53(9):2946-2959. doi: 10.1111/ejn.14699. Epub 2020 Feb 25.
2
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.重印本:重新探讨氧化应激和线粒体功能障碍在帕金森病发病机制中的作用——类似于安非他命类药物滥用的影响。
Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.
3
The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.DJ-1 的去糖基化酶活性减轻多巴胺能细胞中α-突触核蛋白的糖基化和聚集:氧化应激介导的 DJ-1 下调在帕金森病中的作用。
Free Radic Biol Med. 2019 May 1;135:28-37. doi: 10.1016/j.freeradbiomed.2019.02.014. Epub 2019 Feb 20.
4
The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease.α-突触核蛋白与帕金森病中线粒体功能障碍的相互作用。
Biophys Chem. 2023 Dec;303:107122. doi: 10.1016/j.bpc.2023.107122. Epub 2023 Oct 10.
5
Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.鉴定一种在帕金森病中诱导线粒体损伤和自噬的高度神经毒性α-突触核蛋白。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2634-E2643. doi: 10.1073/pnas.1713849115. Epub 2018 Feb 27.
6
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.线粒体功能障碍和帕金森病中的自噬:从家族性到散发性疾病。
Trends Biochem Sci. 2015 Apr;40(4):200-10. doi: 10.1016/j.tibs.2015.02.003. Epub 2015 Mar 8.
7
Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria.α-突触核蛋白的促线粒体毒性与 MAPK 激活有关,涉及到线粒体中 tau 的磷酸化和聚集。
Neurobiol Dis. 2019 Apr;124:248-262. doi: 10.1016/j.nbd.2018.11.015. Epub 2018 Nov 22.
8
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.α-突触核蛋白导致帕金森病中线粒体功能障碍的共同机制。
J Mol Biol. 2023 Jun 15;435(12):167992. doi: 10.1016/j.jmb.2023.167992. Epub 2023 Feb 2.
9
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.线粒体动力学和功能受损在帕金森病发病机制中的作用
Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18.
10
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.α-突触核蛋白:帕金森病中的病理学、线粒体功能障碍和神经炎症。
Neurobiol Dis. 2018 Jan;109(Pt B):249-257. doi: 10.1016/j.nbd.2017.04.004. Epub 2017 Apr 8.

引用本文的文献

1
Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials.针对突触核蛋白病和tau蛋白病中患病蛋白的免疫疗法:来自临床试验的见解
Transl Neurodegener. 2025 Jul 1;14(1):33. doi: 10.1186/s40035-025-00490-9.
2
Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates.用于α-突触核蛋白聚集体成像的正电子发射断层显像剂的研发
Cells. 2025 Jun 16;14(12):907. doi: 10.3390/cells14120907.
3
Unravelling the Proteinopathic Engagement of α-Synuclein, Tau, and Amyloid Beta in Parkinson's Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration.
揭示帕金森病中α-突触核蛋白、 Tau蛋白和β-淀粉样蛋白的蛋白病关联:线粒体崩溃作为神经退行性变的关键驱动因素
Neurochem Res. 2025 Apr 16;50(3):145. doi: 10.1007/s11064-025-04399-7.
4
TCE-mediated neuroprotection against rotenone-induced dopaminergic neuronal death in PD mice: insights into the Nrf-2/PINK1/Parkin-mitophagy pathway.三氯乙烯介导的对帕金森病小鼠中鱼藤酮诱导的多巴胺能神经元死亡的神经保护作用:对Nrf-2/PINK1/帕金蛋白-线粒体自噬途径的见解
Metab Brain Dis. 2025 Apr 7;40(4):172. doi: 10.1007/s11011-025-01595-w.
5
Enhancements in Parkinson's Disease Management: Leveraging Levodopa Optimization and Surgical Breakthroughs.帕金森病管理的进展:利用左旋多巴优化和手术突破
Curr Drug Targets. 2025;26(1):17-32. doi: 10.2174/0113894501319817240919103802.
6
Tet1-mediated activation of the Ampk signaling by Trpv1 DNA hydroxymethylation exerts neuroprotective effects in a rat model of Parkinson's disease.Tet1 通过 TRPV1 DNA 羟甲基化介导激活 Ampk 信号转导在帕金森病大鼠模型中发挥神经保护作用。
Funct Integr Genomics. 2024 Sep 17;24(5):161. doi: 10.1007/s10142-024-01446-4.
7
Neurodegenerative diseases and catechins: (-)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress.神经退行性疾病与儿茶素:(-)-表没食子儿茶素-3-没食子酸酯是慢性神经炎症和氧化应激的调节剂。
Front Nutr. 2024 Aug 1;11:1425839. doi: 10.3389/fnut.2024.1425839. eCollection 2024.
8
Gut-directed therapy in Parkinson's disease.帕金森病的肠道定向治疗。
Front Pharmacol. 2024 Jun 21;15:1407925. doi: 10.3389/fphar.2024.1407925. eCollection 2024.
9
Genetic modifiers of synucleinopathies-lessons from experimental models.突触核蛋白病的基因修饰因子——来自实验模型的经验教训
Oxf Open Neurosci. 2023 Mar 9;2:kvad001. doi: 10.1093/oons/kvad001. eCollection 2023.
10
Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease.线粒体功能障碍作为治疗主要神经退行性疾病的信号靶点。
Neurotox Res. 2023 Dec;41(6):708-729. doi: 10.1007/s12640-023-00647-2. Epub 2023 May 10.